IDH2 and glioblastoma: The presence of at least one of these molecular aberrations in an IDH- and H3-wildtype diffuse glioma is sufficient for the diagnosis of IDH-wildtype GBM, even in the absence of microvascular proliferation and/or necrosis [19].